Le Lézard
Classified in: Health
Subjects: REL, AVO

Statement by Knights of Columbus CEO Carl Anderson on HHS Action to End NIH Research on Fetal Tissue Obtained from Abortions


NEW HAVEN, Conn., June 5, 2019 /PRNewswire/ -- The following is a statement from Carl Anderson, Supreme Knight, Knights of Columbus, on HHS Action to End NIH Research on Fetal Tissue Obtained from Abortions:

(PRNewsfoto/Knights of Columbus)

"The Knights of Columbus applauds the action taken today by the Department of Health and Human Services (HHS) to end research by the National Institutes of Health (NIH) using fetal tissue obtained from elective abortions.  Over the past several years, NIH has spent millions of taxpayer dollars pursuing this unethical research and today's announcement is an important step ensuring that public funding is not used to support a practice that depends on the destruction of innocent human life.  We thank the department for this important action and encourage HHS to ensure that all grants maintain a respect for human life." ? Carl Anderson, Supreme Knight, Knights of Columbus

SOURCE Knights of Columbus


These press releases may also interest you

at 01:00
Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, has announced the appointment of new executive employees to help guide the company towards profitability and long-term success. Jerome Carle, Chief Executive...

20 jui 2019
Agropur Cooperative is recalling Iceberg brand and Originale Augustin brand ice cream sandwiches from the marketplace due to possible presence of fine metal particles. Consumers should not consume the recalled products described below. The following...

20 jui 2019
AKT, founded by celebrity trainer Anna Kaiser, will be taking their cardio-dance, interval and strength training fitness concept on a multi-city tour this summer. Much like a performer, AKT is ready to put on a show for those in local cities, giving...

20 jui 2019
Marker Therapeutics, Inc. , a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced interim...

20 jui 2019
This year on World Brain Day, the World Federation of Neurology (WFN) is raising awareness for migraine, one of the leading causes of global disability. United under the theme "Migraine: The Painful Truth," more than 120 organizations worldwide are...

20 jui 2019
Global laboratory instrumentation manufacturer Fluid Imaging Technologies (http://www.fluidimaging.com) announced today the release of the biggest software update in its history: VisualSpreadsheet Software 5 for the FlowCam automated particle imaging...



News published on 5 june 2019 at 17:50 and distributed by: